Someone pricked your finger in a radiology waiting room, fed a drop of blood into a device the size of a paperback, and two minutes later you were cleared for your scan. Or a report came back with “POC creatinine” printed beside the number. Either way the abbreviation goes unexplained, which is a shame, because what it stands for is genuinely simple and what it implies about your result is worth knowing.
POC stands for point of care. A POC creatinine test measures the creatinine in your blood on a small analyser at the place where you are being seen — a clinic room, a hospital bay, a CT scanner’s waiting area, an ambulance, a village health post — instead of sending a tube of blood to a central laboratory. POCT means point-of-care testing, the same idea with the word “testing” attached. The measurement is the same substance, the same clinical meaning, and usually the same units. What changes is where the blood is analysed, how long you wait, and how much precision you get in exchange for that speed.
That trade is the whole story of this page. A point-of-care result exists because a decision has to be made now — whether to inject contrast dye, whether to give a particular antibiotic dose, whether a patient in a remote clinic needs referring today. It is not a downgraded lab test. It is a different tool for a different moment, with its own strengths and a short list of honest limitations you should understand before you compare it against anything else in your record. If you want the standard venous test explained instead, what creatinine is in a blood test covers that in full, and what counts as a normal creatinine level handles the numbers.
What creatinine is explains the molecule itself and why anyone measures it. Once you have a number in front of you, the Waldev creatinine clearance calculator turns it into an estimate of how well your kidneys are filtering.
On this page
What POC and POCT actually stand for
POC is point of care. POCT is point-of-care testing. You will also see the same concept called near-patient testing, bedside testing, or in older literature ward-based testing. In veterinary practice it is often called in-house testing. All of these describe the same arrangement: the analytical instrument sits within a few metres of the patient, and the person who takes the sample is usually the person who reads the result.
The phrase describes a location, not a chemistry. This trips people up. Seeing “POC creatinine” on a piece of paper tells you nothing about whether the number is high or low, nothing about your kidneys, and nothing about the quality of the sample. It tells you only that the analyser lived in the department rather than in the basement laboratory. The clinical interpretation of the number is unchanged: a creatinine of 180 µmol/L means the same thing whether it came from a cartridge in the emergency department or a large chemistry analyser two floors down.
One further piece of vocabulary. Because the classic point-of-care creatinine device also calculates an estimated glomerular filtration rate from the result, you will frequently see “POC eGFR” alongside it. That is a derived number, not a second measurement — the machine has taken your creatinine, your age and your sex and put them through a published equation. The same equation the laboratory uses. Calculating GFR from creatinine walks through how that arithmetic works if you want to reproduce it yourself.
Quick translation: POC = point of care. POCT = point-of-care testing. Both mean “tested here, not sent away”. Neither says anything about your result.
How a point-of-care test differs from a central laboratory test
Start with what a central laboratory does with a routine venous sample, because the contrast makes everything else clear. Blood is drawn into a tube, labelled, put in a rack, and transported — sometimes by porter, sometimes by pneumatic tube, sometimes by van from a clinic several miles away. At the laboratory it is booked in, centrifuged to separate plasma or serum from the cells, loaded onto a large automated analyser, measured, checked against internal quality control, released by an authorised person, and reported into the electronic record. Every step is documented. Most of the elapsed time is not analysis, it is logistics.
A point-of-care device removes almost all of that. Whole blood goes straight in. Nothing is spun, separated or transported. The analysis runs on a disposable strip or cartridge and the result appears on a small screen. The measurement itself takes somewhere between about thirty seconds and a few minutes depending on the device.
| Feature | Point-of-care creatinine | Central laboratory creatinine |
|---|---|---|
| Where it runs | Clinic room, ED bay, radiology, ambulance, ward, remote outpost | Accredited laboratory, often off site |
| Sample | Whole blood — capillary fingerstick or a small venous drop | Venous tube, typically several millilitres |
| Sample volume | Roughly 1 to 100 microlitres depending on device | Millilitres, though only a fraction is used |
| Preparation | None. No spinning, no separation | Centrifugation to serum or plasma |
| Time to result | About 30 seconds to 5 minutes | Typically 1 to 4 hours in hospital, up to a day or more from a clinic |
| Operator | Nurse, radiographer, doctor, paramedic, trained healthcare assistant | Biomedical scientist |
| Precision | Good, but generally wider than the lab | The reference standard in routine practice |
| Cost per test | Higher per individual test | Lower per test at volume |
| Runs other tests at once | Sometimes — often on a small panel only | Yes, dozens of analytes from one tube |
Two rows in that table deserve more attention than the rest. The time row explains why point-of-care testing exists at all. The precision row explains why it has not replaced the laboratory. Everything else follows from those two.
There is also a structural difference in oversight. Central laboratories run under formal accreditation, with continuous internal quality control and participation in external quality assessment schemes where anonymous samples are sent round and results compared between laboratories. Point-of-care programmes are supposed to do the same thing, and in a well-run hospital they do — there is normally a designated POCT coordinator, a training and competency register for every operator, scheduled quality control runs, and connectivity that pushes results into the patient record automatically. Where point-of-care testing goes wrong, it is far more often a governance failure than a device failure.
Inside the device: strips, cartridges and the chemistry
Two hardware designs dominate, and it is worth knowing which one you met.
The strip meter
Physically similar to a blood glucose meter. A disposable test strip clicks into a handheld reader, you touch a drop of blood to the end, capillary action draws it in, and the result appears in well under a minute. Sample requirements are tiny — some strip systems need only around one or two microlitres, which is a drop far smaller than a pinhead. This is the design you are most likely to meet before a CT scan or in a community clinic.
The cartridge analyser
A slightly larger benchtop or handheld unit takes a single-use cartridge containing the sensors, the calibrating fluid and the waste chamber. You pipette in a small volume of whole blood, seal it, and insert it. These systems often run a whole panel at once — sodium, potassium, urea, creatinine, sometimes blood gases and haematocrit — which is why they are standard in emergency departments and critical care.
The chemistry underneath is usually the same in both, and it is elegant. Creatinine is difficult to measure directly, so the device converts it, step by step, into something easy to detect. A cascade of three enzymes does the work. Creatinine amidohydrolase turns creatinine into creatine. Creatine amidinohydrolase turns that creatine into sarcosine and urea. Sarcosine oxidase then oxidises the sarcosine and, in doing so, produces hydrogen peroxide. Hydrogen peroxide is straightforward to measure at an electrode: it gives up electrons, and the resulting tiny current is directly proportional to how much creatinine was in the drop to begin with.
creatinine → creatine → sarcosine + urea → glycine + formaldehyde + H₂O₂
H₂O₂ oxidised at the electrode → current measured → creatinine concentration reported
That is an enzymatic method, and it is the same family of chemistry used by most modern central laboratories. It matters because the older laboratory alternative — the Jaffe reaction, which uses picric acid in alkaline conditions to produce an orange-red colour — reacts with several substances in blood that are not creatinine, and therefore reads slightly high in some people. A point-of-care enzymatic result and a laboratory enzymatic result are conceptually closer to each other than a Jaffe result is to either.
Because the sample is whole blood rather than plasma, most devices also have to correct for the proportion of the sample occupied by red cells. Creatinine lives in the water phase of blood, so a sample packed with red cells contains less plasma per microlitre. Better systems measure haematocrit on the same strip and adjust automatically. That correction is one of the quiet engineering achievements that made handheld creatinine viable at all, and its limits are covered further down.
The sample: a fingerstick instead of a tube
For most people this is the visible difference. Rather than a tourniquet, a needle and a vacuum tube, you get a spring-loaded lancet against the side of a fingertip and a single drop of blood. It takes seconds, needs no phlebotomy skill, and is easier in people with difficult veins, in frail older patients, and in anyone who dreads a needle.
Capillary blood is not identical to venous blood in every respect, but for creatinine the agreement is close enough to be clinically usable, which is why the technique was adopted in the first place. What matters far more is technique. A finger squeezed hard to force out blood brings tissue fluid with it and dilutes the sample. A finger still wet with alcohol gel contaminates the drop. A first drop not wiped away can carry skin debris. These are ordinary, avoidable errors, and they are the commonest reason a point-of-care result looks wrong.
Warm the hand first. Poor perfusion in a cold fingertip means slow, meagre flow and more temptation to squeeze.
Let the alcohol dry completely. Residual disinfectant on the skin alters the sample.
Wipe the first drop, use the second. Standard practice for capillary sampling generally.
Do not milk the finger. Firm repeated squeezing dilutes blood with interstitial fluid and can shift the reading.
Apply the drop promptly. Capillary blood begins to clot quickly once it is outside the body.
Cartridge systems in hospitals more often use a small volume of venous or arterial blood taken from an existing line, which sidesteps all of the above. If you are an inpatient with a cannula already in place, the point-of-care sample may be drawn without any additional needle at all.
Turnaround: why minutes instead of hours is the entire point
A creatinine result that arrives four hours late is not a worse result. It is often a useless one, because the decision it was meant to inform has already been made without it. That single sentence explains why hospitals buy these devices.
Consider the difference in practical terms. An outpatient arrives for a contrast-enhanced CT scan with no recent blood test on file. Under the laboratory route, the appointment is either cancelled and rebooked for another day, or the patient waits in the department for several hours while a sample travels, is processed and is reported. Under the point-of-care route, a radiographer pricks a finger in the waiting area and has a number before the patient has finished changing.
The value is not only the patient’s time. Cancelled and rebooked scans waste an imaging slot that cannot be refilled at short notice, and they delay a diagnosis that may be the reason the scan was ordered. The same logic applies in an emergency department, where knowing kidney function early changes antibiotic choices, changes anticoagulant dosing, and changes whether a contrast study happens at all. It applies in a rural clinic where the nearest laboratory is a two-hour drive and the patient may not return.
What speed does not do is improve accuracy. Nobody buys a point-of-care creatinine analyser because it measures better. They buy it because a good-enough number now beats a perfect number later, in a specific set of situations where later is too late. Recognising which situation you are in is the skill.
Where point-of-care creatinine is actually used
The settings differ but the underlying question is identical every time: does someone need to act on kidney function before a laboratory could possibly reply?
Radiology, before contrast
The single largest use. Iodinated contrast for CT, and some MRI contrast agents, are handled by the kidneys, so departments check filtration before injecting. A finger-prick screen lets a patient with no recent blood result be assessed on the spot rather than sent away.
Emergency departments
Cartridge analysers producing creatinine alongside potassium, urea and blood gases within minutes. Used to spot acute kidney injury early, to guide fluid decisions, and to make safe drug choices before laboratory results land.
Primary care and community clinics
Where an immediate decision matters — a patient being started on a medicine that needs a renal check, a housebound person seen at home, an anticoagulation or heart failure clinic adjusting therapy in a single visit rather than across two appointments.
Remote and resource-limited settings
Places with no nearby laboratory, no reliable cold chain and no realistic sample transport. A battery-powered analyser with room-temperature strips can be the only route to a creatinine at all, and it turns a screening programme into something achievable.
Ambulances and pre-hospital care
Less widespread, but growing. A crew attending an unwell patient at home can measure kidney function and potassium before deciding on transfer, destination and urgency.
Dialysis and renal units
Used for rapid checks around treatment and for assessing residual kidney function, though established renal units usually have quick laboratory access, so the gain is smaller than elsewhere.
Operating theatres and critical care
Blood gas analysers on the unit often include creatinine on the panel. Kidney function during and after major surgery can change fast, and waiting hours between measurements loses the trend.
Veterinary practice
In-house biochemistry is routine in small animal clinics, where a cat or dog is anaesthetised or treated the same day and there is no option to wait for an external laboratory. Covered in its own section below.
One recurring use deserves naming separately: drug dosing. A large number of medicines are cleared by the kidneys and are dosed according to estimated clearance, and getting that wrong in either direction causes harm. Creatinine clearance and drug dosing explains the principle, and the mechanics of the estimate itself are covered in what creatinine clearance is. Where a first dose cannot wait — a septic patient needing antibiotics inside the hour — a point-of-care creatinine is often what makes a properly adjusted dose possible.
The contrast scan scenario, explained in full
Most people who search for this term met it in a radiology department, so this deserves the space.
A contrast-enhanced CT scan involves injecting an iodine-based dye into a vein. The dye makes blood vessels, organs and abnormalities show up clearly, and without it many scans would answer nothing. That dye is cleared from the body almost entirely by the kidneys. Two questions follow. Can your kidneys clear it? And could the dye itself make your kidney function worse?
Why the department checks first
The concern has a name: post-contrast acute kidney injury, historically called contrast-induced nephropathy. It means a rise in creatinine in the days after a contrast injection. The understanding of it has changed considerably. For years any creatinine rise after a scan was blamed on the dye, but studies comparing patients who had contrast against similar patients who had unenhanced scans found that much of the apparent effect was down to the underlying illness rather than the dye. The risk from intravenous contrast in people with normal or mildly reduced kidney function is now regarded as very low.
Very low is not zero, and it is not evenly spread. Risk concentrates in people whose filtration is already substantially reduced, in people who are acutely unwell or dehydrated, in those with an acute kidney injury already under way, and in those receiving contrast directly into an artery. So departments screen. The point of the screen is not to find a reason to cancel — it is to identify the small group who need extra precautions.
What the number is compared against
The device reports creatinine and calculates an eGFR. Local protocols vary, but the widely used dividing line in adult practice sits at an eGFR around 30 mL/min/1.73m². Above that, intravenous contrast for a routine CT is generally given without special measures. Below it, or where kidney function is known to be changing rapidly, the radiologist and referring team weigh the value of the scan against the risk, and may arrange intravenous fluids before and after, consider a lower contrast dose, use a different imaging technique, or proceed anyway because the diagnostic need outweighs a small risk.
Some protocols use a second threshold, often around eGFR 45, to trigger a discussion rather than a precaution. And a few departments screen only patients with risk factors — known kidney disease, diabetes, heart failure, age above a certain cut-off, relevant medicines — rather than everyone. If you were asked a short questionnaire before the scan, that is what it was for.
| Screening result | What typically happens next |
|---|---|
| eGFR comfortably above 30 | Scan proceeds as booked, no additional measures |
| eGFR between roughly 30 and 45 | Usually proceeds; some protocols prompt a check of hydration and medicines |
| eGFR below 30 | Radiologist reviews. Options include hydration before and after, reduced contrast volume, an alternative scan, or proceeding when the diagnosis matters more |
| Result close to a threshold | Often confirmed on a laboratory sample before a final decision |
| Known dialysis patient | Handled by a specific local protocol, frequently coordinated with dialysis timing |
| Unexpectedly abnormal in someone previously normal | Prompts a laboratory check and a look for an acute cause rather than an automatic cancellation |
If your result comes back abnormal
The most common outcome is not cancellation. It is a conversation. A radiologist looks at the number, at why the scan was requested, and at your history, then decides. A scan looking for a suspected cancer or a possible aortic problem carries a very different weight from a routine follow-up that could safely wait a fortnight.
It is also worth knowing that an abnormal screening result is sometimes the most useful thing that happens to a patient that day. People walk into radiology with silently reduced kidney function they knew nothing about. A finger-prick before a scan can be the first indication, which then gets confirmed properly and followed up. If that happened to you, what high creatinine means and when to worry about creatinine levels are the sensible next reads — and a single abnormal point-of-care value is a reason for a proper laboratory test, not a diagnosis in itself.
MRI contrast is a separate question
Gadolinium agents used in MRI are a different substance with a different concern. The historical worry was nephrogenic systemic fibrosis, a rare and serious condition seen in people with severely reduced kidney function who received certain older gadolinium agents. Modern agents classed as lower risk have made this very rare indeed, but MRI departments still check filtration before using some agents, and the same point-of-care screening is used. If you were finger-pricked before an MRI rather than a CT, that is why.
Worth saying plainly: being screened before a scan does not mean anyone suspects your kidneys are damaged. It is a routine safety check applied to large numbers of people, the great majority of whom pass it without a second thought.
How accurate is a POC creatinine, honestly
Good, with caveats that matter more at some values than at others. That is the short answer, and the long answer is worth reading because the caveats are the reason clinicians treat these numbers the way they do.
Modern point-of-care creatinine systems correlate closely with laboratory measurement across the ordinary range. Published method-comparison studies generally find agreement that is clinically acceptable for screening purposes, with most paired results falling within a small absolute difference of the laboratory value. For the purpose these devices are used for — deciding whether someone is comfortably above a threshold — that is entirely adequate.
Now the caveats.
Precision is wider. Run the same sample repeatedly on a laboratory analyser and the spread of results is very tight. Run it on a handheld device and the spread is wider. Neither is wrong; one is simply more repeatable. In practice this means a point-of-care value carries a slightly larger margin of uncertainty around it than the number on screen suggests.
Bias is not identical across the range. Some devices agree beautifully with the laboratory at normal values and drift a little at high ones, or the reverse. A device validated mainly in a screening population is being asked to do something different when it is used on a patient with advanced kidney disease.
Small creatinine differences become larger eGFR differences. The relationship is not linear. At low creatinine values a difference of a few micromoles per litre barely shifts the eGFR; near a decision threshold it can move the estimate by several units and push a patient across a protocol line. This is the most clinically important consequence of reduced precision.
Operator technique contributes real error. Squeezed fingers, contaminated drops, expired or badly stored strips, a device out of calibration. In routine use, technique and consumables cause more discrepancies than the underlying analytical chemistry does.
Extremes of haematocrit degrade performance. Very anaemic or very polycythaemic blood challenges the correction the device applies, and manufacturers state a haematocrit range within which results are valid.
Put together, the sensible position is the one most hospitals adopt: trust the point-of-care result when it sits clearly away from a decision threshold, and confirm it in the laboratory when it sits close to one, when it conflicts with what you expected, or when it is going to be used for anything beyond the immediate decision. A result of eGFR 78 in a well outpatient needs no confirmation. A result of eGFR 31 in the same patient probably does.
There is one more honest limitation, and it applies to laboratory creatinine just as much. Creatinine is an imperfect marker of kidney function in the first place. It depends on muscle mass, diet, hydration and several medicines, so an unusually muscular person or someone with very little muscle will have a creatinine that misrepresents their filtration regardless of which machine measured it. What creatinine actually measures unpacks that, and how much creatinine levels fluctuate covers the day-to-day variation that exists before any instrument is involved.
What interferes with a point-of-care creatinine result
Every measurement method has substances that confuse it. Knowing the list explains most surprising results.
| Interfering factor | Why it matters | Practical note |
|---|---|---|
| Haematocrit outside the stated range | The device converts a whole-blood measurement to a plasma-equivalent value and needs to know the red cell fraction | Severe anaemia or marked polycythaemia can shift results; manufacturers publish a valid range |
| Ascorbic acid (vitamin C) | An electron donor that can react at the electrode used to detect hydrogen peroxide | High-dose supplements or intravenous vitamin C are the realistic scenario, not dietary intake |
| Paracetamol at high concentration | Similar electrochemical interference at therapeutic-plus levels on some systems | Relevant in overdose or high-dose intravenous use rather than ordinary tablets |
| Creatine supplements | Raises measured creatinine genuinely, through production, and can also interact with the enzyme cascade on some systems | Tell whoever tests you. Covered in does creatine raise creatinine |
| Certain drugs and infusions | Dopamine, hydroxyurea and some others appear on manufacturer interference lists | Device-specific; hospital protocols usually flag the relevant ones |
| Dehydration | Not an interference at all — a genuine physiological rise in creatinine | Explained in can dehydration raise creatinine |
| Poor sampling technique | Tissue fluid dilution, alcohol contamination, partial clotting | The commonest cause of an implausible result in real practice |
| Strip or cartridge storage | Heat, humidity and expiry degrade the enzymes | A particular issue in hot climates and in vehicles |
Separately from device interference, several medicines raise measured creatinine without reducing filtration at all, by blocking the tubular secretion route that a portion of creatinine normally uses to leave the body. Trimethoprim and cimetidine are the classic examples. That effect is real on every method, laboratory and point-of-care alike, and it explains a lot of otherwise puzzling results. Medications that raise creatinine lists them.
Are POC devices standardised to the same reference material?
Mostly yes, and the answer matters more than it sounds.
Creatinine measurement went through a large international standardisation effort because results differed unacceptably between laboratories, which made eGFR equations unreliable. The fix was to anchor every method to a common reference — a certified pure creatinine material, with values assigned by isotope dilution mass spectrometry, the most accurate technique available. Methods calibrated to that chain are described as IDMS-traceable, and the eGFR equations in use today assume that traceability.
Reputable point-of-care creatinine systems state traceability to that same reference material, which is what allows a device to calculate an eGFR at all. So the calibration anchor is shared. What is not shared is the residual method-specific difference: two traceable systems can both be correctly calibrated and still return values that differ by a small, systematic amount because of how each handles whole blood, haematocrit and interferents. Traceability narrows the gap between methods. It does not close it.
The practical consequence: a point-of-care creatinine and a laboratory creatinine drawn from the same person at the same minute may differ slightly, and both can be correct within their stated performance. That difference is method, not biology — which leads directly to the next section.
Why you should not trend a POC result against a lab result
This is the single most useful thing on this page, and it is routinely ignored.
Suppose your creatinine was 92 µmol/L at your GP surgery in March, measured in a laboratory. In July you are finger-pricked before a CT scan and the device says 104. Has your kidney function declined by thirteen percent in four months? Possibly. Or possibly not, because you have compared two different measurement systems, and a proportion of that gap may be the systematic offset between them plus the wider imprecision of the handheld device plus the ordinary biological variation that exists between any two samples from the same healthy person.
Interpreting change requires that everything except the thing you are measuring stays the same. Switching instrument breaks that. The rule clinicians use is straightforward.
Trend laboratory results against laboratory results, ideally from the same laboratory using the same method. Trend point-of-care results against point-of-care results from the same device type.
A change that appears only when you switch instruments is a prompt to repeat properly, not evidence of decline.
If a point-of-care value would start a medicine, stop a medicine, trigger a referral or cancel a procedure, it is worth a laboratory sample to stand on.
Muscle mass, recent meat intake, hydration, exercise in the previous day or two and current medicines all move creatinine. Record what was true on the day.
Two values make a line. Four or five make a trend, and a trend is what actually tells you something.
This is the same reasoning behind not mixing estimation equations when tracking function over time. Cockcroft-Gault compared with MDRD shows how much two published formulas can differ on identical inputs, and creatinine clearance compared with GFR explains why the two numbers are not interchangeable either. Consistency of method is what makes a sequence of results meaningful.
Seeing “POC” on your lab report
Results from point-of-care devices are usually filed into the same electronic record as laboratory results, which is exactly what you want — nobody benefits from a number that exists only on a printout in a drawer. To stop the two being confused, they are labelled. That label is what you are looking at.
Common forms it takes: a prefix or suffix on the test name such as “POC creatinine” or “creatinine (POCT)”; a source field naming the device or the ward; a comment attached to the result along the lines of “point-of-care result, not laboratory verified” or “for immediate clinical use, confirm with laboratory sample if required”; or a separate section of the record where near-patient results are grouped.
What the label does mean
The sample was analysed on a device outside the main laboratory, generally on whole blood, without the laboratory’s authorisation step. It was intended to answer a question at that moment. It may have a slightly wider uncertainty than a laboratory value and should not be lined up directly against laboratory results in a trend.
What it does not mean
It is not a warning about your result. It is not a sign anyone doubted the number. It carries no information about whether your creatinine is high, low or normal, and it is not a lower grade of test. A POC label on a completely normal creatinine means your creatinine was completely normal.
You may also see the units differ between reports. Most of the world reports creatinine in micromoles per litre, the United States in milligrams per decilitre, and the conversion is a fixed factor of about 88.4 — so 1.0 mg/dL is roughly 88 µmol/L. A device set to one unit and a laboratory reporting in the other produces two numbers that look alarmingly unlike each other and are identical. Serum creatinine explained covers how the value is reported and what sits alongside it on a typical panel.
Home and consumer creatinine testing, and where it stops
The obvious question follows: if a nurse can measure creatinine from a finger-prick in two minutes, why can you not do it at home like a blood glucose reading?
Technically you almost can. The barriers are regulatory, economic and interpretive rather than purely technical. Handheld creatinine analysers are sold as professional devices, priced for clinics, and supplied with consumables that expect controlled storage and periodic quality control. Approving a device for unsupervised consumer use is a much higher bar than approving it for a trained operator, and the market is far smaller than the diabetes market that made glucose meters cheap.
What does exist for consumers falls into three groups, and they are not equivalent.
Mail-in blood kits
You collect a small blood sample at home, usually by finger-prick onto a card or into a microtube, and post it to a laboratory. The analysis is a real laboratory analysis. This is not point-of-care testing at all — the location of the measurement is the laboratory — and turnaround is days, not minutes.
Smartphone urine tests
A dipstick photographed against a colour reference card, with an app reading the result. The established consumer version measures albumin and creatinine in urine to produce an albumin-to-creatinine ratio, which screens for kidney damage. It is genuinely point-of-care, but it is a urine test measuring a different thing from a blood creatinine.
Professional devices used privately
Some private clinics, occupational health services and pharmacies run the same handheld analysers hospitals use. That is a legitimate point-of-care creatinine, performed by someone trained, and the result carries the same strengths and caveats described above.
What is not reliable
Unbranded strips sold online with no regulatory clearance, no stated performance data and no quality control. A creatinine value from an unvalidated source is worse than no value, because it invites either false reassurance or unnecessary alarm.
The urine albumin-to-creatinine ratio deserves a note, because it is the consumer kidney test most people actually encounter and it is easy to confuse with a blood creatinine. It measures how much albumin is leaking into your urine, using urine creatinine only as a correction for how dilute the sample is. It answers a different question — kidney damage rather than kidney filtration — and the two tests are complementary. How the albumin-creatinine ratio is calculated explains the arithmetic, and urine creatinine explained covers why it appears in that calculation at all.
The deeper limit on home creatinine testing is not the measurement. It is what you would do with it. A creatinine of 118 µmol/L means nothing without your age, sex, muscle mass, medication list, hydration on the day, and ideally a previous value measured the same way. That is interpretation, and it is the part a device cannot supply. If you want to convert a number you already have into a clearance estimate, the creatinine clearance calculator will do the arithmetic, but the arithmetic was never the hard part.
Point-of-care creatinine in veterinary practice
Some readers arrive here from the animal side, because in-house biochemistry is more normal in veterinary medicine than in human medicine and “POC” appears constantly on veterinary result sheets.
The reason is structural. A small animal practice frequently has to make a decision within one appointment: is this cat well enough to anaesthetise, is this vomiting dog in kidney failure, does this elderly patient need fluids admitting today. Sending blood to an external laboratory means a result tomorrow, and the animal is in front of you now. So most practices run a benchtop analyser that produces creatinine, urea, electrolytes and liver markers from a small sample within minutes.
The interpretive difference is worth flagging. Reference ranges are species-specific and differ substantially between cats and dogs, and creatinine has a well-known blind spot in cats, where a large proportion of kidney function can be lost before the blood value rises above the normal range at all. That is why many practices also measure SDMA, a marker that tends to rise earlier in the course of feline kidney disease, and why urine concentrating ability is assessed alongside the blood result rather than after it. If you are dealing with a diagnosis in a pet, lowering creatinine levels in cats and lowering creatinine in dogs naturally cover the management side.
Do not cross the species line. Human reference ranges do not apply to animals and animal ranges do not apply to people. A creatinine that is unremarkable in a healthy dog would be interpreted very differently in a person, and vice versa. Veterinary results belong with a vet.
Who checks that the device is right
A laboratory analyser is surrounded by infrastructure most patients never see: internal quality control run at intervals through the day, external quality assessment where unknown samples are circulated between laboratories and results compared, formal accreditation, and scientists whose job is to notice drift. A handheld device in a busy department has none of that by default. It has to be built around it deliberately.
In a well-run point-of-care programme that means a named coordinator responsible for every device in the organisation, a register of trained operators with periodic reassessment, lockout functions that prevent an untrained user or an out-of-date device from producing a result, scheduled quality control material run on each analyser, automatic transfer of results into the patient record so nothing depends on transcription, and periodic comparison of device results against the laboratory using split samples.
Where those things are in place, point-of-care creatinine performs reliably in real-world use. Where they are not — a device bought by one department, used by whoever is on shift, with strips kept in a warm cupboard and results copied onto paper — the risk is not that the technology fails. It is that nobody notices when it does. If you ever want to ask an intelligent question about a point-of-care result, “when was this analyser last quality controlled?” is a better one than “is this machine accurate?”
What to ask if you are given a point-of-care result
You are handed a number in a corridor and given about forty seconds to respond. These are the questions worth spending them on.
What is the number, and what are the units? Write it down, with mg/dL or µmol/L attached. A value without units is impossible to compare with anything later.
What eGFR did the device calculate? That is usually the figure the protocol is based on, and it is the one you will want if you look anything up afterwards.
Is this going into my record? Most systems file automatically. Some standalone devices do not, and a result that never reaches your notes cannot inform anything later.
Does it need confirming in the laboratory? Reasonable whenever the result is near a decision threshold, unexpected, or going to change your treatment.
Should this be followed up with my GP? The critical question if the result was abnormal. A pre-scan screen is not a diagnostic workup, and an abnormal screen needs someone to own the follow-up.
Did anything on the day affect it? Mention creatine supplements, a large meat meal, heavy training, dehydration, vomiting, or a recently started medicine. Any of these can move the number and the person testing you has no way of knowing.
If the result was normal and the scan or procedure went ahead, there is genuinely nothing further to do. If it was abnormal, the follow-up matters more than the number did. A single reading is a snapshot, and kidney function is judged on trends, on urine testing and on clinical context. The normal creatinine clearance range gives you the reference figures to hold it against, and the CrCl calculator is the quickest way to put your own value into context. Pregnancy is one situation where standard reference ranges shift meaningfully, and creatinine levels in pregnancy covers that separately.
For the wider picture of how creatinine testing fits into kidney assessment generally, MedlinePlus has a plain-language overview of the creatinine test, and the National Kidney Foundation explains what estimated GFR means and how the stages are defined. Both are worth ten minutes if you have just been given a result you did not expect.
Frequently asked questions
What does POC mean on a lab report?
POC stands for point of care. It means the sample was analysed on a device near you — in the clinic room, the emergency department, the radiology suite — rather than sent to a central laboratory. It is a label describing where the test ran, not a comment on your result. A POC creatinine of 85 µmol/L means exactly what a laboratory creatinine of 85 µmol/L means. The only practical implication is that the value carries slightly wider measurement uncertainty and should not be lined up directly against laboratory results when tracking change over time.
What is the difference between POC and POCT?
Almost nothing. POC is point of care, describing the setting. POCT is point-of-care testing, describing the activity that happens there. Reports and requests use them interchangeably, so “POC creatinine” and “POCT creatinine” mean the same test. You may also encounter near-patient testing, bedside testing, or in-house testing in veterinary practice — all the same concept. None of these terms tells you anything about the technology used, the quality of the result, or what the number means clinically.
Why did they prick my finger before my CT scan?
To check your kidney function before injecting contrast dye. The iodine-based contrast used in CT is cleared by the kidneys, so departments confirm that filtration is adequate before proceeding, particularly if you have no recent blood test on file or you have risk factors such as diabetes, known kidney disease or heart failure. The finger-prick gives a creatinine and an estimated GFR in about two minutes, which means you can be assessed and scanned in the same visit instead of being sent away and rebooked. Most people pass without any further discussion.
Is a point-of-care creatinine as accurate as a lab test?
Close, but not identical. Modern devices correlate well with laboratory measurement across the usual range and are entirely adequate for the screening decisions they are used for. They are generally less precise, meaning repeated measurements of the same sample spread a little wider, and small differences in creatinine translate into larger differences in estimated GFR near decision thresholds. The standard approach is to trust the result when it sits clearly away from a threshold and confirm it in the laboratory when it sits close to one or would change your treatment.
Can I compare my POC result to my last lab result?
Not directly, and this catches a lot of people out. Two different measurement systems can each be correctly calibrated and still return slightly different values on the same blood, so a gap between a laboratory result from March and a device result from July may be method rather than biology. Add ordinary day-to-day variation and the comparison becomes unreliable. Trend laboratory against laboratory, and point-of-care against point-of-care. If a cross-method change looks significant, the answer is to repeat it properly rather than to conclude anything.
How does a handheld creatinine device actually work?
A drop of whole blood is drawn into a disposable strip or cartridge containing three enzymes. The first converts creatinine to creatine, the second converts creatine to sarcosine, and the third oxidises the sarcosine and releases hydrogen peroxide in the process. Hydrogen peroxide is easy to detect electrically: it gives up electrons at a sensor, producing a tiny current proportional to the original creatinine concentration. The device also corrects for haematocrit, because it measured whole blood rather than plasma, then reports the result and calculates an eGFR.
What can make a POC creatinine result wrong?
Sampling technique is the biggest real-world contributor: squeezing the finger hard dilutes the drop with tissue fluid, wet alcohol contaminates it, and a delayed drop may have started to clot. Beyond that, haematocrit outside the device’s stated range, high-dose vitamin C, very high paracetamol concentrations, certain infused drugs, and strips stored in heat or past expiry can all shift results. Creatine supplements raise the value genuinely rather than falsely. Any implausible result should be repeated, ideally on a fresh laboratory sample.
Can I buy a creatinine test for home use?
Not in the way you can buy a glucose meter. Handheld creatinine analysers are sold as professional devices with consumables that assume trained operators and quality control. What you can buy is a mail-in blood kit, which is a laboratory test with a home collection step, or a smartphone-read urine dipstick that measures the albumin-to-creatinine ratio — a different test answering a different question. Avoid unregulated strips sold online with no published performance data, since an unreliable number is worse than none.
Does a POC creatinine need to be repeated in the lab?
It depends entirely on what the result is being used for. A normal value in a well person, used only to clear them for a routine scan, needs no repeat. A value close to a protocol threshold, an unexpected abnormality in someone with no known kidney problem, or any result that would start or stop a medicine generally does get confirmed on a laboratory sample. Ask directly if nobody mentions it. An abnormal screening result also needs someone named to follow it up, usually your GP.
Does the POC device measure eGFR or calculate it?
It calculates it. The device measures creatinine only, then puts that value together with your age and sex into a published estimating equation and displays the result. It is the same arithmetic a laboratory performs. Because the relationship between creatinine and eGFR is not linear, a small measurement difference at low creatinine values barely moves the estimate, while the same difference near a threshold can shift it by several units. That is why borderline eGFR results from any method are treated cautiously.
The short version
POC means point of care and POCT means point-of-care testing. A POC creatinine is measured on a small analyser beside you, on a drop of whole blood, in about thirty seconds to a few minutes, instead of being sent to a central laboratory. The chemistry is a three-enzyme cascade ending in hydrogen peroxide detected electrically, and the device calculates an eGFR from the result. Most people meet it as a finger-prick before a contrast CT scan, where the department is checking filtration before injecting dye that the kidneys have to clear.
Accuracy is good but precision is wider than the laboratory, small creatinine differences become larger eGFR differences near thresholds, and results close to a decision line are often confirmed properly. The rule worth remembering is not to compare a point-of-care value directly against an old laboratory value, because part of any gap is method rather than biology. Put your own number in context with the CrCl calculator, and read further across the creatinine blog category, the wider health blog, the full set of health calculators, and the rest of the tool library at waldev.com.
Medical disclaimer: This article is general educational information about how a laboratory measurement is performed and cannot interpret your individual result. It is not medical advice and must not be used to decide whether to seek care, delay care, or change any treatment or medication. Reference ranges and local protocols vary between services, and any result must be read alongside your history, medications, symptoms and other tests. Always discuss your own results with a doctor or qualified healthcare professional. Seek urgent medical attention if you have much reduced urine output, new swelling of the legs or face, breathlessness, confusion or persistent vomiting.
MedlinePlus explains what a creatinine test is, why it is ordered and what the results mean. Creatinine test overview →
The National Kidney Foundation on estimated GFR, the ranges, and how the stages are defined. Estimated GFR explained →
NIDDK on the blood and urine tests used to assess kidney disease and how they fit together. CKD tests & diagnosis →